Dr. Lloyd Clark graduated with Honors from the University of North Carolina School of Medicine, where he was inducted into the Alpha Omega Alpha Medical Honor Society.

He completed Ophthalmology Residency at Bascom Palmer Eye Institute, consistently ranked as the #1 training program in the United States, followed by a fellowship in Vitreoretinal Diseases and Surgery at the world-renowned Cleveland Clinic Foundation.

Dr. Clark is board certified by the American Board of Ophthalmology. In addition to his clinical practice, he is also Assistant Clinical Professor of Ophthalmology at the University of South Carolina School of Medicine, where he helps train the next generation of ophthalmologists. He has received an Achievement Award from the American Academy of Ophthalmology as well as an Honor Award by the American Society of Retinal Specialists. He is also an active member of The Retina Society. He has published more than 30 peer-reviewed journal articles and book chapters. He lectures nationally and internationally as both an invited speaker and at scientific congresses.

Dr. Clark’s research interests include both drug and device development to improve clinical outcomes in retinal disease. He has been an investigator in dozens of NIH and industry-sponsored trials and has been an author on seminal papers on the application of anti-VEGF agents for both adult and pediatric retinal disease. At present, his research is centered on next generation therapeutics to treat age-related macular degeneration and diabetic eye disease.